Distribution of HIV drugs in poor countries stopped
A legally contested executive order on foreign aid did, at least initially, halt the distribution of life-saving HIV drugs.
The Trump administration has moved to stop the supply of lifesaving drugs for HIV, malaria, and tuberculosis in countries supported by USAID around the globe.
Uganda sought to dispel fears among HIV patients that a US aid freeze will interrupt treatment and promised that such programs will continue.
The Trump administration has made some concessions to the halt placed on distributions of global HIV treatments via the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), according to The New York Times.
Australian and New Zealand aid and support will be crucial in containing Fiji’s serious HIV outbreak – including combating the drug trade that is fuelling it.
A stop in all of PEPFAR’s work shuttered clinics this week. Then, a new exemption for “life-saving” treatment left organizations uncertain.
Almost 136,000 babies are expected to be born with HIV in the next three months, mostly in Africa, because of the Trump administration’s “stop work order” on foreign assistance, according to a top research foundation.
Major barriers in screening for fatty liver disease in patients with HIV included uncertainties about testing, diagnostic data insufficiency, low priority, time constraints, and referral limitations.
“Since its bipartisan creation, PEPFAR has always been synonymous with saving lives and this waiver restores – in some part – that legacy. However, PEPFAR’s continued and uninterrupted support of all HIV treatment and prevention services must be fully restored,” IAS President Beatriz Grinsztejn said.
A Manx poet has released a series of poems in the voice of early AIDS patient Jonathan Blake. Written by Simon Maddrell, ‘Patient L1’ explores the experiences of Blake through poetry, and is based on more than 50 hours of conversation that Maddrell has had with him since 2019.
In Nigeria, PEPFAR remains a major contributor to the treatment of People Living with HIV, covering approximately 90 per cent of the country's treatment needs